Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for Hemodynamic Response to Extubation
NCT04264286Phase 4Unknown
- Sponsor
- Hospital de Base de São José do Rio Preto
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hemodynamic instability comparing Esmolol group with Placebo group (2 arms). Primary endpoint: Number of participants with adverse events as tachycardia at 15 minutes. Status: unknown.
02
Drugs
esmolol
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT04264286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04264286.